Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and InvestigationsPublisher:
ISBN:
Category : Boards of directors
Languages : en
Pages : 80
Book Description
Conflicts of Interest on Blue Shield Boards of Directors
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and InvestigationsPublisher:
ISBN:
Category :
Languages : en
Pages : 80
Book Description
Public Representation on Boards and Blue Shield Allowances
Author: United States. General Accounting OfficePublisher:
ISBN:
Category : Health insurance
Languages : en
Pages : 118
Book Description
Conflicts of Interest on Blue Shield Boards of Directors
Author: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and InvestigationsPublisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Hearings
Author: United States. Congress SenatePublisher:
ISBN:
Category :
Languages : en
Pages : 2970
Book Description
Social Security, Hearings on H.R. 6675 ... 1965
Author: United States. Congress. Senate. FinancePublisher:
ISBN:
Category :
Languages : en
Pages : 1304
Book Description
Social Security
Author: United States. Congress. Senate. Committee on FinancePublisher:
ISBN:
Category : Health insurance
Languages : en
Pages : 820
Book Description
Efforts to Combat Fraud and Abuse in the Insurance Industry: July 2, 29 and 30, 1992
Author: United States. Congress. Senate. Committee on Governmental Affairs. Permanent Subcommittee on InvestigationsPublisher:
ISBN:
Category : Government publications
Languages : en
Pages : 684
Book Description
Efforts to Combat Fraud and Abuse in the Insurance Industry
Author: United States. Congress. Senate. Committee on Governmental Affairs. Permanent Subcommittee on InvestigationsPublisher:
ISBN: 9780160398568
Category : Fraud
Languages : en
Pages : 688
Book Description
Conflict of Interest and Medical Innovation
Author: Institute of MedicinePublisher: National Academies Press
ISBN: 0309301718
Category : Medical
Languages : en
Pages : 88
Book Description
Scientific advances such as the sequencing of the human genome have created great promise for improving human health by providing a greater understanding of disease biology and enabling the development of new drugs, diagnostics, and preventive services. However, the translation of research advances into clinical applications has so far been slower than anticipated. This is due in part to the complexity of the underlying biology as well as the cost and time it takes to develop a product. Pharmaceutical companies are adapting their business models to this new reality for product development by placing increasing emphasis on leveraging alliances, joint development efforts, early-phase research partnerships, and public-private partnerships. These collaborative efforts make it possible to identify new drug targets, enhance the understanding of the underlying basis of disease, discover novel indications for the use of already approved products, and develop biomarkers for disease outcomes or directed drug use. While the potential benefits of collaboration are significant, the fact that the relationships among development partners are often financial means that it is vital to ensure trust by identifying, disclosing, and managing any potential sources of conflict that could create bias in the research being performed together. Conflict of Interest and Medical Innovation is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in June 2013 to explore the appropriate balance between identifying and managing conflicts of interest and advancing medical innovation. A wide range of stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists, patient advocates, and consumers, were invited to present their perspectives and participate in discussions during the workshop. This report focuses on current conflict of interest policies and their effect on medical innovation in an effort to identify best practices and potential solutions for facilitating innovation while still ensuring scientific integrity and public trust.
Author: